Integrated care pathway for rectal cancer treatment
cross-sectional post-implementation study using a logic model framework
Keywords:
Rectal neoplasms, Interdisciplinary studies, Disease management, Implementation science, Decision making, Qualitative researchAbstract
BACKGROUND: Management of rectal cancer has become more complex with multimodality therapy (neoadjuvant chemoradiotherapy and surgery) and this has led to the need to organize multidisciplinary teams. The aim of this study was to report on the planning, implementation and evaluation of an integrat-ed care pathway for neoadjuvant treatment of middle and lower rectal cancer. DESIGN AND SETTING: This was a cross-sectional post-implementation study that was carried out at a public university cancer center. METHODS: The Framework for Program Evaluation in Public Health of the Centers for Disease Control and Prevention (CDC) was used to identify resources and activities; link results from activities and outcomes with expected goals; and originate indicators and outcome measurements. RESULTS: The logic model identified four activities: stakeholders’ engagement, clinical pathway develop-ment, information technology improvements and training programs; and three categories of outcomes: access to care, effectiveness and organizational outcomes. The measurements involved 218 patients, among whom 66.3% had their first consultation within 15 days after admission; 75.2% underwent surgery < 14 weeks after the end of neoadjuvant treatment and 72.7% completed the treatment in < 189 days. There was 100% adherence to the protocol for the regimen of 5-fluorouracil and leucovorin. CONCLUSIONS: The logic model was useful for evaluating the implementation of the integrated care pathways and for identifying measurements to be made in future outcome studies.
Downloads
References
Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90. PMID: 21296855; doi: 10.3322/caac.20107.
Estimativa 2016: incidência do câncer no Brasil/Instituto Nacional de Câncer José Alencar Gomes da Silva. Rio de Janeiro: INCA; 2015. ISBN‑10: 978-85-7318-284-2; ISBN-13: 978-85-7318-283-5.
Zon RT, Frame JN, Neuss MN, et al. American Society of Clinical Oncology Policy Statement on Clinical Pathways in Oncology. J Oncol Pract. 2016;2(3):261-6. PMID: 26759491; doi: 10.1200/JOP.2015.009134.
Rotter T, Kinsman L, James E, et al. Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs. Cochrane Database Syst Rev. 2010(3):CD006632. PMID: 20238347; doi: 10.1002/14651858.CD006632.pub2.
W.K. Kellogg Foundation. Using Logic Models to Bring Together Planning, Evaluation, and Action. Logic Model Development Guide. Battle Creek, MI: W.K. Kellogg Foundation; 2004. Available from: https://www.bttop.org/sites/default/files/public/W.K.%20Kellogg%20LogicModel.pdf. Accessed in 2019 (Oct 16).
Joly BM, Polyak G, Davis M, et al. Linking accreditation and public health outcomes: a logic model approach. J Public Health Man Pract. 2007;13(4):349-56. PMID: 17563622; doi: 10.1097/01. PHH.0000278027.56820.7e.
Anderson L, Petticrew M, Rehfuess E, et al. Using logic models to capture complexity in systematic reviews. Res Synth Methods. 2011;2(1):33-42. PMID: 26061598; doi: 10.1002/jrsm.32.
U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Office of the Director, Office of Strategy and Innovation. Introduction to program evaluation for public health programs: A self-study guide. Atlanta, GA: Centers for Disease Control and Prevention; 2011. Available from: https://www.cdc.gov/eval/guide/CDCEvalManual.pdf. Accessed in 2019 (Oct 16).
Butler MM, Brosnan MC, Drennan J, et al. Evaluating midwifery-led antenatal care: Using a programme logic model to identify relevant outcomes. Midwifery. 2014;30(1):e34-41. PMID: 24246971; doi: 10.1016/j.midw.2013.10.003.
Bosset JF, Collete L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006;355(11):1114-23. PMID: 16971718; doi: 10.1056/NEJMoa060829.
Benson AB 3rd, Bekaii-Saab T, Chan E, et al. Rectal cancer. J Natl Compr Canc Netw. 2012;10(12):1528-64. PMID: 23221790; doi: 10.6004/ jnccn.2012.0158.
Obias VJ, Reynolds HL Jr. Multidisciplinary teams in the management of rectal cancer. Clin Colon Rectal Surg. 2007;20(3): 143-7. PMID: 20011195; doi: 10.1055/s-2007-984858.
Levine RA, Chawla B, Bergeron S, Wasvary H. Multidisciplinary management of colorectal cancer enhancer access to multimodal therapy and compliance with National Comprehensive Cancer Network (NCCN) Guidelines. Int J Colorectal Dis. 2012;27(11):1531-8. PMID: 22645076; doi: 10.1007/s00384-012-1501-z.
Chang KH, Smith MJ, McAnena OJ, Aprjanto AS, Dowdall JF. Increased use of multidisciplinary treatment modalities adds little to the outcome of rectal cancer treated by optimal total mesorectal excision. Int J Colorectal Dis. 2012;27(10):1275-83. PMID: 22395659; doi: 10.1007/ s00384-012-1440-8.
Allen D, Gillen E, Rixson L. Systematic review of the effectiveness of integrated care pathways: what works, for whom, in which circumstances? Int J Evid Based Healthc. 2009;7(2):61-74. PMID: 21631848; doi: 10.1111/j.1744-1609.2009.00127.x.
Fleissig A, Jenkins V, Catt S, Fallowfield L. Multidisciplinary teams in cancer care: are they effective in the UK?. Lancet Oncol. 2006;7(11):935-43. PMID: 17081919; doi: 10.1016/S1470-2045(06)70940-8.
Allen D, Rixson L. How has the impact of “care pathway technologies” on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect? Int J Evid Based Healthc. 2008;6(1):78-110. PMID: 21631815; doi: 10.1111/j.1744-1609.2007.00098.x.
Ludt S, Urban E, Eckardt J, et al. Evaluating the quality of colorectal cancer care across the interface of healthcare sectors. PLos ONE. 2013;8(5):e60947. PMID: 23658684; doi: 10.1371/journal. pone.0060947.
Eldin NS, Yasui Y, Scarfe A, Winget M. Adherence to treatment guidelines in stage II/III rectal cancer in Alberta, Canada. Clin Oncol (R Coll Radiol). 2012;24(1):e9-17. PMID: 21802914; doi: 10.1016/j.clon.2011.07.005.
Gallego-Plazas J, Menárquez-Pina F, Maestre-Peiró A, et al. Feasibility of adequate resectable rectal cancer treatment in a third-level hospital. Clin Transl Oncol. 2009;11(3):172-7. PMID: 19293055; doi: 10.1007/ S12094-009-0334-x.
Wiegering A, Isbert C, Dietz U A, et al. Multimodal therapy in treatment of rectal cancer is associated with improved survival and reduced local recurrence - a retrospective analysis over two decades. BMC Cancer. 2014;14:816. PMID: 25376382; doi: 10.1186/1471-2407-14-816.
Uña E, López-Lara F. Pilot study of a clinical pathway implementation in rectal cancer. Clin Med Insights Oncol. 2010;4:111-5. PMID: 21151842; doi: 10.4137/CMO.S4651.
